Multiple sclerosis (MS), the most common autoimmune neuronal disease, is characterized by an immunological attack against myelin in the CNS (1) . Because the endothelial blood-brain barrier (BBB) tightly restricts leukocyte extravasation, the CNS is usually considered an immune-privileged site, but it is clear that autoreactive T cells breach this barrier in the course of this disease. Similarly, in experimental autoimmune encephalomyelitis (EAE), a disease model closely resembling MS, myelin-specific CD4 + T lymphocytes reach the CNS following adoptive transfer into the peripheral blood (1, 2) .
In a previous milestone study (3) , Yednock and coworkers cast light on this process with their finding that EAE induction can be prevented by administering antibodies against α4 integrins, such as α4β1 (VLA-4). In vitro, peripheral blood lymphocytes and monocytes bind inflamed but not resting brain vessels in a VLA-4-dependent manner (3). VLA-4 is a key leukocyte adhesion receptor that binds to both endothelial VCAM-1 and ECM fibronectin (4). Although myelin-specific autoreactive T clones must cross the CNS vasculature of healthy animals, Yednock and colleagues' results and subsequent studies (2) did not explain how autoreactive T blasts can infiltrate noninflamed CNS while host mononuclear cells fail to interact with CNS microvessels prior to inflammation.
Vascular beds of many extralymphoid tissues must undergo induction of specific proadhesive and stimulatory signals to recruit inflammatory effector leukocytes. Recent evidence suggests that extralymphoid vessels express basal levels of adhesive molecules, which are recognized by specialized subsets of immune cells -potential initiators of inflammatory responses. One remarkable example is the ability of dendritic cell subsets to tether and roll on E-and P-selectins, as well as on ICAM-2, ligands that are constitutively expressed on noninflamed skin endothelium (5, 6) ( Figure  1 ). Consequently, dendritic cells can rapidly extravasate the skin vessels upon any insult, even prior to fullblown inflammation.
Might certain encephalitogenic subsets of T blasts possess a similar capacity to recognize noninflamed CNS vessels? Vajkoczy et al., writing in this issue of the JCI (7), have now provided the first in vivo evidence that EAE-inducing blasts localize to and migrate through the CNS microvasculature of healthy animals. Using a novel intravital microscopy technique that allows them to view the spinal cord, these authors show that encephalitogenic T blasts rely on their α4 integrins to arrest on the vessel wall of the CNS white matter microvasculature. Direct visualization of blasts interacting with CNS vessels, combined with mAb-blocking experiments against both blast α4 integrins and CNS vessel VCAM-1, shows that EAE-inducing blasts are captured by the BBB vessel wall primarily through VLA-4/VCAM-1 interactions (7). Once these blasts enter the CNS, if they are exposed to self antigen, they may then elicit local inflammation and thus induce other adhesive and chemotactic molecules in the nearby vascular bed. This response may thus set the stage for the entry of additional encephalitogenic lymphocytes and effector monocytes ( Figure 1 ).
The present work (7) provides the first demonstration that the α4 integrin-dependence of adoptive transfer of EAE-inducing T blasts (3) arises from the nearly exclusive role played by the VLA-4/VCAM-1 interaction in promoting the attachment of the EAE-inducing blasts to the CNS vasculature. Both postcapillary venules and the capillary network of the CNS is suggested to express functional VCAM-1 on a constitutive basis in healthy animals (7). This VCAM-1, rather than other α4 integrin ligands like MadCAM-1 or the alternatively spliced fibronectin found in various endothelia (4), accounts for the capacity of T blasts to adhere within the microvasculature of the resting CNS (7). Generally, VCAM-1 is inducibly expressed on cytokine-activated endothelia, and therefore some of the CNS vessel expression of VCAM-1 seen in the present study may have been induced by irritation from the surgical operation. However, VCAM-1 is detected at low levels in the CNS even in healthy mice (8) . The finding that anti-VCAM-1 mAb's administered to naive animals prior to or at the time of EAE induction delay onset and severity of disease (2, 9) also supports constitutive VCAM-1 activity on resting CNS vasculature. Despite its sparse levels, CNS-vessel VCAM-1 appears to constitute the major if not the exclusive addressin, or recruitment receptor, controlling the homing of autoreactive VLA-4-expressing T blasts to the CNS. Both VLA-4 expression and affinity to VCAM-1 are higher in blast cells than in resting (naive or memory) T cells (10), potentially accounting for the inherent capacity of these blasts -but not any other leukocyte -to attach stably to endothelial VCAM-1. Indeed, VLA-4 affinity controls the ability of lymphocytes transiently tethered to VCAM-1-bearing surfaces to firmly capture to these surfaces under physiological shear flow (11) .
In contrast to most adhesive cascades established by circulating leukocytes (12) , T blast capture to the CNS vasculature does not appear to involve G iprotein stimulation by endothelial chemokines (13) : Blast capture to the CNS vessels is insensitive to pretreatment with pertussis toxin, a selective blocker of heterotrimeric G i -protein signaling (7). However, this treatment strongly suppresses the ability of blasts to remain firmly bound to the CNS and, subsequently, to extravasate through the BBB endothelium (7) (Figure 1) . It is therefore likely that BBB vessel chemokines, constitutively coexpressed with VCAM-1, can augment VLA-4-dependent blast adhesion on endothelial VCAM-1, and that the strengthening of this interaction represents a key step, necessary for adherent blast to transmigrate through the endothelial barrier (7). In addition, the Vajkoczy et al. study (7) rules out the involvement of LFA-1 integrin in either blast arrest or blast migration through the CNS endothelium.
Another feature of blast associations with the CNS vasculature that sets it apart from leukocyte interactions with most endothelia is that selectins are not involved in the CNS (7, 14) . The absence of selectins and selectin ligands on CNS vasculature renders blast α4 the nearly exclusive receptor responsible for blast capture to the CNS vessel wall. Although α4 can support leukocyte rolling on VCAM-1, both in vitro and in vivo (15) , EAE-inducing blasts do not roll along the CNS vessels but rather arrest immediately after initiating contact with these vessels (7). Highaffinity α4, elevated on T blasts, indeed preferentially mediates leukocyte arrest on VCAM-1-bearing surfaces under shear flow (11, 16) . This adhesive receptor thus bypasses the need for stimulatory G i -protein signaling, a step normally essential for integrin activation and leukocyte arrest on vessel walls (13) . High-affinity α4 also renders T cells more responsive to signals by endothelial chemokines (11), potentially contributing to the G i -protein-dependent migration steps that follow blast capture to CNS vessels (Figure 1 ). In this regard, a striking observation of the Vajkoczy et al. study is the extremely slow rates (hours) at which arrested blasts transmigrate the BBB endothelium (7). These results suggest that transendothelial migration (TEM) of blasts across the BBB is much slower than lymphocyte TEM across high endothelial venules or inflamed endothelial sites, possibly due to the existence of tight endothelial junctions in the BBB endothelium more than in other endothelial beds (17) .
In addition to their specialized highaffinity binding to endothelial VCAM-1, CNS-homing blasts may be able to disrupt the tight BBB junctions by proteolysis. VLA-4 occupancy by VCAM-1 during lymphocyte migra-
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The tion across endothelium has been shown to induce metalloprotease activity (18) . It is thus possible that VLA-4 ligation by endothelial VCAM-1 augments the proteolytic potential of recruited blasts and facilitates their penetration through endothelial or subendothelial barriers.
In conclusion, the new in vivo data of Vajkoczy et al. (7) predict that VCAM-1 is a CNS addressin with constitutive potential to recruit activated T cell subsets expressing high-affinity VLA-4 to BBB vessels (Figure 1 ). Within the CNS microvessels, G i activation, perhaps induced by endotheliumderived chemokines, promotes the subsequent adhesive and migratory processes that allow the recruited T blasts to extravasate through the BBB. Early CNS homing of EAE-inducing T blasts appears to be antigen-independent, since both myelin-specific and -nonspecific T clones migrate to a comparable degree to the CNS (19) .
This apparent constitutive expression of traffic signals for autoreactive blasts on the CNS vasculature poses a paradox. Why should neuronal immune-privileged tissue express recruitment signals for self-destructive lymphocytes? The recent observation that myelin-specific autoreactive T clones can provide protective autoimmunity that is beneficial in CNS injuries (20, 21) suggests a potential solution to this enigma. T blasts may retain inherent capacity to home to the noninflamed CNS, thereby providing a first line of protective immunity to damaged neuronal tissue (21) . MS and EAE pathogenesis may occur when this natural immunosurveillance mechanism of the CNS is deregulated.
